Planet 13 Holdings (PLNH) Non-Current Assets (2021 - 2026)

Planet 13 Holdings' (PLNH) quarterly Non-Current Assets came in at $109.1 million in Q1 2026, down 28.26% year-on-year from $152.1 million in Q1 2025, and down 1.85% on a QoQ basis from $111.1 million in Q4 2025.

Planet 13 Holdings (PLNH) Non-Current Assets (2021 - 2026) Analysis & Trends

Planet 13 Holdings (PLNH) has 6 years of Non-Current Assets data on file, last reported at $109.1 million in Q1 2026.

  • On a quarterly basis, Non-Current Assets fell 28.26% year-over-year to $109.1 million in Q1 2026; TTM through Mar 2026 was $484.9 million, a 28.38% decrease from a year earlier, with the FY2025 full-year figure at $111.1 million, down 27.09% from the prior year.
  • Non-Current Assets for Q1 2026 stood at $109.1 million, down from $111.1 million in the prior quarter.
  • Over the last five years, Non-Current Assets for PLNH reached as high as $197.2 million in Q2 2022 and fell as low as $104.4 million in Q4 2023.
  • Historically, Non-Current Assets has averaged $151.1 million across 5 years, with a median of $152.4 million in 2024.
  • Across the five-year window, Non-Current Assets jumped 51.07% in 2024 and plunged 38.61% in 2025, its largest moves.
  • Year by year, Non-Current Assets stood at $163.1 million in 2022, then tumbled by 35.98% to $104.4 million in 2023, then jumped by 45.96% to $152.4 million in 2024, then slipped by 27.09% to $111.1 million in 2025, then fell by 1.85% to $109.1 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Assets figures were $109.1 million in Q1 2026, $111.1 million in Q4 2025, and $113.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 36.78 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 26.33 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 8.68 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 79.20 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 3.84 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 15.70 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 25.92 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2.47 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 9.64 Bn
10 Planet 13 Holdings 39.35 Mn 23.09 Mn 9.41 Mn 109.08 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 109.08 Mn
Dec 31, 2025 111.14 Mn
Sep 30, 2025 113.43 Mn
Jun 30, 2025 151.21 Mn
Mar 31, 2025 152.06 Mn
Dec 31, 2024 152.44 Mn
Sep 30, 2024 184.78 Mn
Jun 30, 2024 187.76 Mn
Mar 31, 2024 104.64 Mn
Dec 31, 2023 104.44 Mn
Sep 30, 2023 122.31 Mn
Jun 30, 2023 163.36 Mn
Mar 31, 2023 166.01 Mn
Dec 31, 2022 163.13 Mn
Sep 30, 2022 194.78 Mn
Jun 30, 2022 197.15 Mn
Mar 31, 2022 191.02 Mn
Dec 31, 2021 135.80 Mn